Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid–Mediated Troglitazone Hepatotoxicity. Issue 5 (28th July 2014)
- Record Type:
- Journal Article
- Title:
- Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid–Mediated Troglitazone Hepatotoxicity. Issue 5 (28th July 2014)
- Main Title:
- Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid–Mediated Troglitazone Hepatotoxicity
- Authors:
- Yang, K
Woodhead, J L
Watkins, P B
Howell, B A
Brouwer, K L R - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Troglitazone (TGZ) causes delayed, life‐threatening drug‐induced liver injury in some patients but was not hepatotoxic in rats. This study investigated altered bile acid homeostasis as a mechanism of TGZ hepatotoxicity using a systems pharmacology model incorporating drug/metabolite disposition, bile acid physiology/pathophysiology, hepatocyte life cycle, and liver injury biomarkers. In the simulated human population, TGZ (200–600 mg/day × 6 months) resulted in delayed increases in serum alanine transaminase &gt;3× the upper limit of normal in 0.3–5.1%, with concomitant bilirubin elevations &gt;2× the upper limit of normal in 0.3–3.6%, of the population. By contrast, pioglitazone (15–45 mg/day × 6 months) did not elicit hepatotoxicity, consistent with clinical data. TGZ was not hepatotoxic in the simulated rat population. In summary, mechanistic modeling based only on bile acid effects accurately predicted the incidence, delayed presentation, and species differences in TGZ hepatotoxicity, in addition to predicting the relative liver safety of pioglitazone. Systems pharmacology models integrating physiology and experimental data can evaluate drug‐induced liver injury mechanisms and may be useful to predict the hepatotoxic potential of drug candidates.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>96</bold> 5, 589–598. doi:<ext-link ext-link-type="doi"<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Troglitazone (TGZ) causes delayed, life‐threatening drug‐induced liver injury in some patients but was not hepatotoxic in rats. This study investigated altered bile acid homeostasis as a mechanism of TGZ hepatotoxicity using a systems pharmacology model incorporating drug/metabolite disposition, bile acid physiology/pathophysiology, hepatocyte life cycle, and liver injury biomarkers. In the simulated human population, TGZ (200–600 mg/day × 6 months) resulted in delayed increases in serum alanine transaminase &gt;3× the upper limit of normal in 0.3–5.1%, with concomitant bilirubin elevations &gt;2× the upper limit of normal in 0.3–3.6%, of the population. By contrast, pioglitazone (15–45 mg/day × 6 months) did not elicit hepatotoxicity, consistent with clinical data. TGZ was not hepatotoxic in the simulated rat population. In summary, mechanistic modeling based only on bile acid effects accurately predicted the incidence, delayed presentation, and species differences in TGZ hepatotoxicity, in addition to predicting the relative liver safety of pioglitazone. Systems pharmacology models integrating physiology and experimental data can evaluate drug‐induced liver injury mechanisms and may be useful to predict the hepatotoxic potential of drug candidates.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>96</bold> 5, 589–598. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2014.158</ext-link></p> </abstract> … (more)
- Is Part Of:
- Clinical pharmacology & therapeutics. Volume 96:Issue 5(2014)
- Journal:
- Clinical pharmacology & therapeutics
- Issue:
- Volume 96:Issue 5(2014)
- Issue Display:
- Volume 96, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 96
- Issue:
- 5
- Issue Sort Value:
- 2014-0096-0005-0000
- Page Start:
- 589
- Page End:
- 598
- Publication Date:
- 2014-07-28
- Subjects:
- Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗ - DOI:
- 10.1038/clpt.2014.158 ↗
- Languages:
- English
- ISSNs:
- 0009-9236
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3358.xml